Overview: Uterine fibroids are the most common benign tumors of the female reproductive system, with an incidence of 25-30% in women over 35 years of age. Clinical symptoms include excessive menstruation, anemia, and a feeling of lower abdominal cramping. Large tumors may lead to frequent urination and difficulty in defecation, and in cases of co-infection, fever and increased leucorrhea and odor, which can lead to infertility in severe cases. Asymptomatic people can reach 37%. Clinical manifestations: Most people may not have any manifestations in the early stage. The symptoms of uterine fibroids are related to the site where it occurs. The uterus is divided into two parts, one is the uterine body and the other is the cervical part. 80% or 90% of the fibroids occur in the uterus, and the uterine body is divided into several parts. Some important organs, such as the bladder in front of it, are present. The impact of fibroids on fertility is also quite significant, with 20% to 30% of cases of infertility, especially in young women, since a major problem for menstruating women is fertility. The incidence of tumors is relatively high and tends to occur in women of childbearing age. For example, in the reproductive age, everyone may have more or less fibroid problems during their reproductive years. In general, about 70% or 80% of people have fibroid problems, but they are very small, have no symptoms and do not go to check. The effects are infertility, miscarriage after pregnancy, premature birth, and complications during delivery. As an obstetrician, it is more difficult to deal with the problem, because there is a child in the belly, and the use of some drugs can have an impact on the fetus in the belly. This is the effect on the pregnancy. Diagnosis: With typical clinical manifestations, ultrasound (color ultrasound), CT, and MRI can yield a clear diagnosis, with color ultrasound being the first test, but sometimes MRI is needed to further clarify the diagnosis. Treatment: Interventional techniques are used to treat uterine fibroids with good results. The procedure consists of sending a very thin catheter into the uterine arteries bilaterally and injecting an embolic agent to cause necrosis and atrophy of the fibroids by blocking their blood supply, with an efficiency of 96% and a low recurrence rate. Compared with conventional gynecological surgery, interventional treatment of uterine fibroids has the following advantages: 1) less surgical trauma due to the use of arterial cannula injection; 2) avoidance of uterine resection and preservation of reproductive function and female secondary sexual characteristics; 3) fewer complications and faster recovery of patients. The safety of interventional therapy has been studied from the following aspects: 1. Clinical studies: including operation time and treatment effect. The operation time is closely related to radiation safety. Skilled interventional operation technique is the key to shorten the operation time and improve the safety of interventional treatment. We have a team with rich experience in interventional treatment and skilled operation skills, which is the fundamental guarantee to improve the safety of surgery and reduce the occurrence of intraoperative hazard rate. 2.Clinical efficacy study: We have used postoperative follow-up and imaging examination to confirm that 90% of the patients’ symptoms have significantly improved or disappeared, and imaging examination has found that the myoma has significantly shrunk or disappeared, and the interventional treatment has less bleeding, less pain and shorter hospitalization time. 3.Angiological study: Postoperative review of ultrasound and MRI showed that there was no blood supply in the myoma, while the normal uterus could detect the blood flow signal, indicating that embolization treatment could be the myoma blood supply stagnation, making the myoma necrotic and shrinking, while embolization of uterine artery would not cause serious ischemia in the normal myometrium. 4. Reproductive endocrinology study: including the effect of interventional treatment on ovarian endocrine function and reproductive function of patients. We found through the analysis of female hormone six before and after embolization that as long as the appropriate embolic agent is applied to avoid excessive embolization of ovarian branches and ovarian tissues, the damage to ovarian function by interventional treatment can be prevented and has no effect on reproductive function.